• Small Molecules
      • Discovery
        Development
        Manufacturing
    • Large Molecules
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
    • Investors
      Corporate Governance
  • Careers

Syngene reports second quarter results Revenue from operations up 26% to Rs. 768 crores PAT increased 11% to Rs. 102 crores

Know More
Know More

Research that changes the world for the better

We are accelerating drug innovation and development for companies globally
More
More

Annual Report FY2021-22

Know More
Know More

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

More
More

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.

Discovery

Our Discovery Services span the entire spectrum of early stage research from target …

More
More

Development

Our Development Services encompass activities from pre-clinical to clinical trials…

More
More

Manufacturing

Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

More
More

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

More
More

InstaVisit - Visit Syngene Virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

View Now
View Now
Visit Syngene virtually with a 360 degree view of Syngene’s world-class facilities and capabilities
0 +

Active Clients

0

Collaborations with top 20 Pharma/Biotech companies

3000 +

Scientists

0

Mn sq. ft. of R&D and manufacturing infrastructure

0 +

Patents 

Latest news

View all
View all

Artificial Intelligence – a game changer in revolutionizing drug discovery

More
News
12th Nov, 2022

Syngene and the Research and Innovation Circle of Hyderabad (RICH) launch scholarship program for women studying STEM subjects

More
Press Release
9th Nov, 2022

Syngene reports second quarter results Revenue from operations up 26% to Rs. 768 crores, PAT increased 11% to Rs.102 crores

More
Press Release
19th Oct, 2022

Insights

View all
View all

Five questions that determine the success of your PROTAC programs

Challenges in developing PROTACs and critical questions to help you assess whether Syngene can help to successfully propel your PROTAC molecules from Target to IND.
More

Solving problems with science: Gene to GMP-grade clinical supply in nine months

How Syngene’s proprietary data platform is safely and efficiently reducing the time taken to produce mAbs from gene to GMP-grade clinical supply by several months.
More

Minimizing environmental footprint the Syngene way

How Syngene is driving behavioural change in responsible use of natural resources while researching new technology and opportunities to improve its sustainability performance continuously.
More

Upcoming events

View all
View all
No data was found

Corporate social responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.
More
More

Syngene International Ltd

+1.35(0.32%)+1.35(0.32%)

Governance

Behind consistent growth is good governance

More
More

Careers

Discover a world of opportunities

More
More

Annual Reports

Touching a billon lives through innnovation

More
More

Sign-up for our newsletter

© 2022. Syngene International Limited

Twitter Linkedin-in Youtube Facebook-f

Quick Links

Business

Get In Touch

Other Links

Twitter Linkedin-in Youtube Facebook-f

© 2022. Syngene International Limited

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

Close
Close

To view or email, Please share your details view

To download, Please share your details